某院处方前置审核中给药途径模块存在的问题及优化策略

Existing problems and optimization strategies of the administration route module in the implementation of prescription pre-review in a hospital

目的分析某院在推进处方前置审核中给药途径模块存在的问题,并构建基于循证证据的给药途径审核模式,促进临床安全用药。方法收集某院2022年4月~9月门诊和住院审方系统弹窗警示的所有给药途径不适宜问题,进行回顾性分析。根据循证证据结合临床需求,构建给药途径的精细化审核规则。结果2022年4月~9月某院门诊和住院给药途径不适宜问题共3584例,主要集中在静脉注射(17%)、静脉滴注(11%)、外用(8%)、局部注射(8%)。优化后的给药途径审核机制既满足了临床需要,又能保证临床合理用药。结论基于循证证据结合临床需求构建个性化的审核规则库,提高了处方审核的效率和临床对审核系统的认可度,同时也保障了患者用药安全。

Objective To analyze the existing problems of the administration route module in the implementation of prescription pre-review in a hospital,to construct audit model of administration route based on evidence-based evidence,and to promote rational clinical use of medications.Methods All the inappropriate issues of administration route in the outpatient and inpatient prescription review systems from April to September 2022 were collected and retrospectively analyzed.Personalized audit rules for route of administration were constructed based on evidence-based evidence combined with clinical needs.Results From April to September 2022,there were 3584 cases of inappropriate routes of administration in a hospital,mainly focusing on intravenous injection(17%),intravenous drip(11%),topical use(8%),and local injection(8%).The optimized audit mechanism of route of administration not only meet the clinical needs,but also ensured the rational clinical use of medication.Conclusion The personalized audit rules were constructed based on evidence-based evidence combined with clinical needs,which improve the efficiency of prescription review and clinical acceptance of the audit system,and ensure the safety of patients’medication use.